Joe Nocera

02/13/2017 - 5:00pm

    What was the target audience for those commercials that ran during that glorious Super Bowl Sunday night? (I'm from New England.)

    You know the ads I'm talking about -- the ones that were less about selling a product than conveying a sentiment about America. The Budweiser ad that depicted...

02/07/2017 - 1:00pm

    It wasn't all that long ago -- though it seems that way, admittedly, with the never-ending flood of Trumpian news -- that I was prepared to acknowledge that President Donald Trump actually has a few good ideas. Or at least one.

    It was Tuesday...

01/31/2017 - 8:00am

    When I wrote about Tom Price's health-care stocks on Tuesday, I was in a state of high dudgeon. Rep. Price, R-Georgia, President Donald Trump's nominee to be secretary of Health and Human Services, has a portfolio clotted with pharmaceutical, medical device and health-care companies -- this...

01/20/2017 - 10:45am

    At first glance, it sure seems as though President-elect Donald Trump is having his way with big corporations. No sooner does he slam a fist on his desk, demanding that companies add American jobs, than they issue press releases promising to oblige.

  ...

11/05/2015 - 8:45am

    Opinions.

    That’s what we do in Op-Ed: We render informed opinions that we hope are smart and sometimes provocative, backed up by good, old-fashioned shoe leather. I’m heading off to a new...

10/30/2015 - 10:00am

    Valeant Pharmaceuticals is a sleazy company.

    Although it existed before 2010, it did a deal that year that put it on the map. The deal was with Biovail, one of Canada’s largest drugmakers — and a...

Syndicate content